Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Spain Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20122
20131
20143
20172
20182
20192
20202
20215
20224
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting11
Recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Pfizer3
Agios Pharmaceuticals, Inc.2
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Seagen Inc.2
Takeda2
AOP Orphan Pharmaceuticals AG1
Amgen1
Ariad Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases29
Bone Marrow Diseases7
Hemorrhagic Disorders7
Lymphoma, Non-Hodgkin6
Anemia5
Lymphoma, B-Cell5
Blood Coagulation Disorders4
Genetic Diseases, Inborn4
Hemophilia A4
Immune System Diseases4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.